Pharmaceutical design and development of perfluorocarbon nanocolloids for oxygen delivery in regenerative medicine
- 1 October 2019
- journal article
- review article
- Published by Future Medicine Ltd in Nanomedicine
- Vol. 14 (20), 2697-2712
- https://doi.org/10.2217/nnm-2019-0260
Abstract
Perfluorocarbons (PFCs) have been investigated as oxygen carriers for several decades in varied biomedical applications. PFCs are chemically and biologically inert, temperature and storage stable, pose low to no infectious risk, can be commercially manufactured, and have well established gas transport properties. In this review, we highlight design and development strategies for their successful application in regenerative medicine, transplantation and organ preservation. Effective tissue preservation strategies are key to improving outcomes of extremity salvage and organ transplantation. Maintaining tissue integrity requires adequate oxygenation to support aerobic metabolism. The use of whole blood for oxygen delivery is fraught with limitations of poor shelf stability, infectious risk, religious exclusions and product shortages. Other agents also face clinical challenges in their implementation. As a solution, we discuss new ways of designing and developing PFC-based artificial oxygen carriers by implementing modern pharmaceutical quality by design and scale up manufacturing methodologies.Keywords
This publication has 114 references indexed in Scilit:
- Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion DesignBiosensors, 2013
- A novel probe for the non-invasive detection of tumor-associated inflammationOncoImmunology, 2013
- Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)Journal of Inflammation, 2012
- 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cellsMagnetic Resonance in Medicine, 2011
- Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: Experimental and modeling studiesJournal of Biotechnology, 2010
- Fluorine (19F) MRS and MRI in biomedicineNMR in Biomedicine, 2010
- 19F MRI for quantitative in vivo cell trackingTrends in Biotechnology, 2010
- The Immunological Properties of Stroma-free Polyhemolysate Containing Catalase and Superoxide Dismutase Activities Prepared by Polymerized Bovine Stroma-free HemolysateArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2010
- Ischemia/reperfusion injury: The role of immune cellsWorld Journal of Cardiology, 2010
- In vivo cytometry of antigen‐specific t cells using 19F MRIMagnetic Resonance in Medicine, 2009